A Review of Patient Preferences for Osteoporosis Drug Treatment

Treatment Satisfaction in Postmenopausal Women Suboptimally Adherent to Bisphosphonates Who Transitioned to Denosumab Compared With Risedronate or Ibandronate

(2015) Santiago Palacios et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

How Important Is Mode of Administration in Treatments for Rheumatic Diseases and Related Conditions?

(2015) Nick Bansback et al.   Current Rheumatology Reports

Discrete Choice Experiments in Health Economics: A Review of the Literature

(2014) Michael D. Clark et al.   PHARMACOECONOMICS

Patients’ preferences for osteoporosis drug treatment: a discrete-choice experiment

(2014) Mickaël Hiligsmann et al.   ARTHRITIS RESEARCH & THERAPY

Using Discrete Choice Experiment to elicit patient preferences for osteoporosis drug treatments: where to from here?

(2014) Tracey-Lea Laba   ARTHRITIS RESEARCH & THERAPY

Influence of patient perceptions and preferences for osteoporosis medication on adherence behavior in the Denosumab Adherence Preference Satisfaction study

(2013) David L. Kendler et al.   MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY

Shared Decision Making to Improve Care and Reduce Costs

(2013) Emily Oshima Lee et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patient Preferences for the Treatment of Type 2 Diabetes: A Scoping Review

(2013) Susan M. Joy et al.   PHARMACOECONOMICS

Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis

(2013) Mickael Hiligsmann et al.   Patient Preference and Adherence

Osteoporosis in the European Union: medical management, epidemiology and economic burden

(2013) E. Hernlund et al.   Archives of Osteoporosis

Patient weighting of osteoporosis medication attributes across racial and ethnic groups: a study of osteoporosis medication preferences using conjoint analysis

(2012) S. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland

(2012) Mickaël Hiligsmann et al.   VALUE IN HEALTH

Use of a Decision Aid to Improve Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial

(2011) Victor M. Montori et al.   AMERICAN JOURNAL OF MEDICINE

Monthly or weekly bisphosphonate? Evaluation of satisfaction in patients with postmenopausal osteoporosis using OPSAT-Q questionnaire during the BOOSTER study in Croatia

(2011) Tonko Vlak et al.   CLINICAL RHEUMATOLOGY

Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™

(2011) E. Barrett-Connor et al.   OSTEOPOROSIS INTERNATIONAL

Final results of the DAPS (Denosumab Adherence Preference Satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women

(2011) N. Freemantle et al.   OSTEOPOROSIS INTERNATIONAL

Antifracture Efficacy of Currently Available Therapies for Postmenopausal Osteoporosis

(2010) Jean-Yves Reginster   DRUGS

Patient preferences for osteoporosis in Spain: a discrete choice experiment

(2010) J. Darbà et al.   OSTEOPOROSIS INTERNATIONAL

Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate

(2010) D. L. Kendler et al.   OSTEOPOROSIS INTERNATIONAL

Adherence and profile of non-persistence in patients treated for osteoporosis—a large-scale, long-term retrospective study in The Netherlands

(2010) J. C. Netelenbos et al.   OSTEOPOROSIS INTERNATIONAL

Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women

(2009) Yoon-Sok Chung et al.   CALCIFIED TISSUE INTERNATIONAL

Patient preference and acceptability of calcium plus vitamin D3 supplementation: a randomised, open, cross-over trial

(2009) Debby den Uyl et al.   CLINICAL RHEUMATOLOGY

Patient Satisfaction in Postmenopausal Women Treated with a Weekly Bisphosphonate Transitioned to Once-Monthly Ibandronate

(2009) Sydney Lou Bonnick et al.   JOURNAL OF WOMENS HEALTH

Preference for weekly and monthly bisphosphonates among patients with postmenopausal osteoporosis: results from the Croatian PROMO Study

(2008) Darko Kastelan et al.   CLINICAL RHEUMATOLOGY

Treatment preference for monthly oral ibandronate and weekly oral alendronate in women with postmenopausal osteoporosis: A randomized, crossover study (BALTO II)

(2008) Peyman Hadji et al.   JOINT BONE SPINE

Patients’ preferences for osteoporosis drug treatment: a discrete choice experiment

(2008) E. W. de Bekker-Grob et al.   OSTEOPOROSIS INTERNATIONAL